A federal court has brought the issue of abortion back into the national spotlight, just months before the midterm elections. The court's decision to restrict mail-order mifepristone, the first drug in a two-drug regimen commonly used in medication abortion, has been seen as one of the most significant battles over abortion since Roe v. Wade was overturned in Dobbs v. Jackson Women’s Health Organization. However, the Trump administration has remained silent on the issue, frustrating the anti-abortion base. This decision could pose a political headache for the Trump Administration and Republicans in tough races. Abortion rights advocates are hopeful they can use this lawsuit to raise the issue back into voters' consciousness.